J Keith Johnson

Title: J Keith Johnson: Innovator in Biologically Active Protein Release

Introduction

J Keith Johnson is a notable inventor based in Hudson, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of sustained release compositions for biologically active proteins. His work has implications for various therapeutic applications, enhancing the delivery and efficacy of important biological agents.

Latest Patents

Johnson holds a patent for "Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins." This invention focuses on the development of sustained release compositions and methods for the effective delivery of biologically active proteins, specifically targeting the sustained release of β-IFN. The composition comprises a biocompatible polymer that contains a stabilized formulation of the protein and a nonionic polymer surfactant, which aids in the controlled release of the active ingredients.

Career Highlights

Throughout his career, Johnson has been associated with Alkermes Controlled Therapeutics, Inc., where he has contributed to innovative research and development projects. His expertise in microencapsulation and sustained release technologies has positioned him as a key player in the biotechnology sector.

Collaborations

Johnson has worked alongside notable colleagues, including Mark A Tracy and Kevin L Ward. Their collaborative efforts have further advanced the research and development of sustained release formulations, enhancing the potential for therapeutic applications.

Conclusion

J Keith Johnson's contributions to the field of biotechnology, particularly through his patent on sustained release compositions, highlight his innovative spirit and dedication to improving therapeutic delivery systems. His work continues to influence the development of effective treatments in the medical field.